Skip to content
Search

Latest Stories

Growth patterns in the first 1,000 days can shape child's future growth: Studies

The authors of these studies related to SDG 2, “Zero Hunger,” emphasise the critical importance of gaining awareness about these trends

Growth patterns in the first 1,000 days can shape child's future growth: Studies

Trends of wasting and stunted growth observed during the initial 1,000 days of a child's life can have lasting impacts on their future health and growth, according to studies newly published in Nature journal's Progress towards the Sustainable Development Goals (SDG) Collection.

The authors of these studies related to SDG 2, "Zero Hunger," emphasise the critical importance of gaining awareness about these trends. They underscore that understanding which populations and age groups require the greatest focus is crucial for addressing growth faltering in children.


The studies present longitudinal, or long-term, analyses of 33 previously published studies by analysing data from overall 80,000 children from across South Asia, sub-Saharan Africa and Latin America.

The Collection marks the mid-point of the 15-year period envisioned by the United Nations to achieve the SDGs by 2030, Nature's press statement said.

The first study, from Stanford University, found that the onset of stunted-growth was most prevalent within the first three months after a child's birth, with south Asia seeing substantially higher stunting at birth.

Jade Benjamin-Chung and colleagues analysed data of 52,640 children in this study.

During these three months, wasting was seen to "peak", the second study, from the University of California (UC) Berkeley, found.

Nearly 30 per cent of the children studied lost fat and muscle tissue in the first two years of life and 10 per cent experienced two or more episodes of wasting, Andrew Mertens from UC Berkeley and team found after studying child wasting in a subset of 11,448 children.

Faltering in growth in the first six months of life was found to lay the ground for subsequent and persistent growth faltering in these children, found the third study, also by Mertens and team, adding that boys had a higher risk of growth faltering than girls.

The study evaluated the potential causes and consequences of child growth failure in 83,671 children.

Wasting experienced early in life heightened the risk of growth faltering in future, Mertens said, even as their team found wasting in the first six months to be associated with faster recovery than in older children.

Reversal of stunting between 0 and 15 months was rare and in children who's stunting was reversed, relapse was frequent, Benjamin-Chung and team found.

These findings emphasised the importance of interventions to improve general maternal and infant health in the first 1,000 days, as well as household environment and sanitation, the researchers said.

Our findings suggest that defining stunting targets at earlier ages (for example, stunting by 3 or 6 months) would help focus attention on the period when interventions may be most impactful, Benjamin-Chung and team said in their study regarding SDG 2.2.1, which aims to reduce stunting prevalence among children under 5 years by 2025.

SDG 2.2 calls for the elimination of malnutrition by 2030, with child wasting as its primary indicator.

Our results elevate the importance of improving at-birth child outcomes, with a focus on both maternal support during pregnancy and nutritional supplementation in food-insecure populations for women of child-bearing age, pregnant women, and children under 24 months, Mertens and team wrote in their study analysing child wasting trends.

(PTI)

More For You

Weight Loss Drug

Health officials expect the rollout to benefit around 220,000 adults over the next 3 years

iStock

NHS GPs to prescribe Mounjaro in nationwide obesity treatment plan

Key points

  • NHS GPs in England can now prescribe Mounjaro (tirzepatide) for weight loss
  • The programme aims to support 220,000 people over three years
  • Eligible patients must have a BMI over 40 and at least four obesity-related health issues
  • GP leaders raise concerns over increased workload
  • Pharmacists urge a broader weight management approach

NHS expands obesity treatment with Mounjaro

The NHS in England is set to begin prescribing Mounjaro, a weight loss injection, through GP surgeries starting Monday. The move marks the first time family doctors will be authorised to directly prescribe the anti-obesity drug tirzepatide as part of a wider national health initiative.

Health officials expect the rollout to benefit around 220,000 adults over the next three years. The drug will be made available to those with a body mass index (BMI) above 40 who also suffer from at least four other obesity-related conditions, such as type 2 diabetes, high blood pressure, or sleep apnoea.

Keep ReadingShow less
UK heatwave deaths

Around 85% of the projected deaths are likely to involve people over the age of 65

iStock

Scientists warn current UK heatwave may cause nearly 600 early deaths

Almost 600 premature deaths are expected to occur during the ongoing heatwave affecting England and Wales, according to a new rapid analysis by leading scientists. The majority of fatalities are projected among older adults, with London and the West Midlands likely to be the worst-affected areas.

Climate change driving deadly temperatures

Researchers say the extreme temperatures, which have reached 32°C in parts of south-east England, would have been nearly impossible without the influence of human-caused climate change. Pollution from burning fossil fuels has raised the likelihood of such heatwaves by around 100 times, experts say.

Keep ReadingShow less
From silence to spotlight: How Ella D’Verma turned her truth into power

In a world still catching up with the truths of trans identity

Instagram / elladverma

From silence to spotlight: How Ella D’Verma turned her truth into power

AS Pride Month sweeps across the world in a blaze of colour, protest and celebration, one Indian voice continues to rise with unwavering authenticity. Ella D’Verma is reshaping narratives as a transgender model, fearless LGBTQ+ advocate and digital content creator with a powerful global following.

In a world still catching up with the truths of trans identity, her visibility has become vital – the embodiment of pride in action. In this exclusive conversation with Eastern Eye, she speaks about her journey, the importance of visibility, self-expression, navigating the fashion industry as a trans model, representation, and her vision for the future.

Keep ReadingShow less
Amycretin

'The Lancet' and presentations at the American Diabetes Association’s 2025

iStock

New weight-loss pill Amycretin shows greater impact than jabs, study finds

A new weight-loss drug, amycretin, has delivered the most significant results yet for appetite-suppressing GLP-1 medications, according to two newly published studies in The Lancet and presentations at the American Diabetes Association’s 2025 Scientific Sessions in Chicago.

Record weight loss from Amycretin injections

Researchers found that participants receiving high-dose weekly injections of amycretin lost 24.3 per cent of their body weight over 36 weeks. This outcome surpasses the results seen in longer trials involving other GLP-1 drugs such as tirzepatide (sold as Mounjaro), which previously led the field with an average weight loss of 20 per cent over 72 weeks.

Keep ReadingShow less
Asian representation Parkinson’s awareness

Organisations like Parkinson’s UK are so vital.

Instagram/ itsmitamistry

Joining the movement: Championing Asian representation and Parkinson’s awareness through sport

Mita Mistry

I recently joined the incredible team at the Asian Sports Foundation. It is an honour to work alongside passionate individuals such as Shazia Ali, Harleen Kaur and Angus Martin. Since it was founded by Jug Johal, the Asian Sports Foundation has worked to transform inactivity into active living, promoting better wellbeing and greater representation of Asian communities in sport and physical activity.

This is a cause close to my heart. The undeniable power of sport and movement to improve both physical and mental health cannot be overstated. It is a message I have consistently championed, alongside a commitment to equity and inclusion, which is why I am so excited to contribute to a charity that truly embodies this ethos.

Keep ReadingShow less